In FLCCC’s inaugural Educational Conference, Dr. Paul Marik, Chief Scientific Officer, and Dr. Pierre Kory, Chief Medical Officer, brought together 14 of the top experts in the field of pathology, evaluation, and treatment of spike protein-induced diseases.
Stream the lectures and download the slide presentations to get exclusive access to all the facts, data, and references.Dr. Asher Milgrom’s presentation will focus on the three primary mechanisms of damage identified as the cause of the cascade of progressive and debilitating symptoms in Long CV19 patients, whether from contracting the virus and/or from the vaccines.
He will then review three of the five modalities AMA Regenerative Medicine has been using that have proven remarkably effective. These include IV Ozone Therapy, EBOO /F, and a variety of IV therapies, the majority of which effectively target mitochondrial health.
These, together with stem cells and hyperbaric oxygen, have resulted in a speedy and complete recovery for approximately 70% of their patients.
The rest, though not yet optimally recovered, have achieved at least sufficient functional recovery to “re-engage” in the full range of daily activities. Of course, we continue to search for more effective treatments for them.
Founded by a group of leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) is dedicated to helping prevent and treat COVID.
We aim to save lives and improve health by advancing protocols based on the latest science, data, and clinical observations.
Our founding physicians are highly published and world-renowned thought leaders, with deep knowledge and expertise to diagnose and treat COVID-related symptoms.
To date, the organization has reached millions of people through its protocols, website, webinars, newsletters, social media, speaking engagements and media appearances. Our protocols are in use by healthcare providers around the world and have helped many thousands of people.
The complex myriad of symptoms in people suspecting of COVID-19 vaccine injury has been given a new name and an extensive treatment protocol: “Post-COVID-19 vaccines syndrome,” said Dr. Paul Marik, co-founder and Chief Science Officer of the Frontline COVID-19 Critical Care Alliance (FLCCC), on Oct. 15 at a conference in Orlando, Florida, aimed at education and sharing information on treating spike protein-induced health issues.
Many alternative treatments were also discussed to improve cell repair and reduce inflammation. Dr. Asher Milgrom, CEO of AMA Regenerative Medicine & Skincare Inc., through a pre-recorded video offered options of ozone therapy to improve mitochondrial dysfunction—a common driver of fatigue.AMA Regenerative Medicine & Skincare | 1570 Brookhollow Dr., Santa Ana, CA 92705 | 6310 San Vicente Blvd STE 285, Los Angeles, CA, 90048 Disclaimer: though everything on our website comes directly from reputable publications and scientific journals; and though thousands of these articles are available on official government websites (https://pubmed.ncbi.nlm.nih.gov), they have not been evaluated by the Food and Drug Administration and the FDA has not certified, endorsed or approved any of the scientific findings as methods of treating or diagnosing any diseases or illnesses.